Windtree Therapeutics, Inc. (WINT) Financials
WINT Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2025 | 16.0 million | 27.6 million |
| June 30, 2025 | 31.8 million | 28.2 million |
| March 31, 2025 | 26.8 million | 16.5 million |
| Dec. 31, 2024 | 27.9 million | 17.9 million |
WINT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2025 | -6.4 million | 17000 |
| June 30, 2025 | -2.7 million | 32000 |
| March 31, 2025 | -2.4 million | 72000 |
| Dec. 31, 2024 | -3.7 million | 21000 |
WINT Net Income
No data available :(
WINT Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2025 | 204000 | - | 784000 |
| June 30, 2025 | 301000 | - | 912000 |
| March 31, 2025 | 1.2 million | - | 1.0 million |
| Dec. 31, 2024 | 1.8 million | - | 1.2 million |
WINT Shares Outstanding
WINT Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2025 | - | 1.9 million | 1.9 million | - |
| June 30, 2025 | - | 2.2 million | 1.8 million | - |
| March 31, 2025 | - | 2.3 million | 1.8 million | - |
| Dec. 31, 2024 | - | 2.2 million | 2.2 million | - |
WINT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2025 | - | 360000 |
| June 30, 2025 | - | 17000 |
| March 31, 2025 | 90000 | 17000 |
| Dec. 31, 2024 | 90000 | 18000 |
WINT
Price: $0.02
52 week price:
Payout Ratio Range:
Earnings Per Share: 323.08 USD
P/E Ratio: 0.00
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 214600
Market Capitalization: 674175